Arch_Twitter_Logo.png
Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities
January 06, 2022 07:50 ET | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch_Twitter_Logo.png
Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound System
December 13, 2021 07:50 ET | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch_Twitter_Logo.png
Arch Therapeutics Launches Experts in Wound Care Program
October 18, 2021 07:50 ET | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Innosphere Ventures Fund leads investment into bioscience company, GelSana Therapeutics
September 21, 2021 10:41 ET | Innosphere Ventures
Golden, CO and Fort Collins, CO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Innosphere Ventures Fund (Fund), a venture capital fund leading early-stage investments, has announced its second seed-stage...
Primatrix products
Integra LifeSciences Announces Positive Clinical Outcomes for PriMatrix® Dermal Repair Scaffold for the Management of Diabetic Foot Ulcers
July 19, 2021 16:30 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, today announced positive clinical outcomes...
fior-markets-logo.jpg
Global Skin and Wound Care Market Is Expected to Reach USD 25.98 Billion by 2025 : Fior Markets
March 04, 2020 08:00 ET | Fior Markets
Newark, NJ, March 04, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global skin and wound care market is expected to grow from USD 18.49 Billion in 2017 to USD 25.98...
Organogenesis_Logo_Corporate.jpg
Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz
January 24, 2019 10:00 ET | Organogenesis Holdings Inc.
CANTON, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
Smith & Nephew France Receives Prix Galien Award
Smith & Nephew wins prestigious Galien Award for PICO Negative Pressure Wound Therapy innovation
December 21, 2016 03:30 ET | Smith & Nephew Plc
PARIS, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Smith & Nephew, (LSE:SN) (NYSE:SNN), the global medical technology business, has been awarded the 2016 French Galien Award for PICO; the novel single-use...
Minister of Industry Inaugurates Fish Skin Medical Device Facility
September 26, 2011 14:56 ET | Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwire - Sep 26, 2011) - Iceland's Minister of Industry Katrin Juliusdottir today inaugurated the Kerecis Medical Device manufacturing facility in...